Immunotech Statements
69
Data from Immunotech`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
CNY - Chinese yuan
Last reporting period:
30 Jun, 2023
Next reporting period:
27 Dec, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Immunotech Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
—
—
—
74.315
25.035
96.193
-29.1 %
-96.193
29.1 %
-22.182
-0.144
-118.6
33.7 %
—
-118.11
33.6 %
-0.23
514.58
—
—
100
—
0
—
—
0
62.414
0
51.455
0
135.67
-5.7 %
0
-135.67
5.7 %
0
-29.577
0
-13.061
0
-178.9
-25.8 %
0
—
0
-177.78
-26.7 %
0
-0.345
514.58
—
—
100
—
0
—
—
0
86.498
0
46.253
0
143.89
-23 %
0
-143.89
23 %
0
2.709
0
-0.72
0
-142.2
31.3 %
0
—
0
-140.33
32.2 %
0
-0.273
514.58
—
—
100
—
0
—
—
0
125.69
0
62.101
0
186.98
26.9 %
0
-186.98
-26.9 %
0
-20.371
0
0.303
0
-207.01
-40.2 %
0
—
0
-206.93
-40.5 %
0
-0.402
514.58
—
—
100
—
0
—
—
0
100.43
0
42.153
0
147.37
-34.1 %
0
-147.37
34.1 %
0
-0.815
0
-0.591
0
-147.6
44.3 %
0
—
0
-147.3
44.4 %
0
-0.286
514.58
—
—
100
—
0
—
—
0
177.1
0
41.378
0
223.56
84.2 %
0
-223.56
-84.2 %
0
-38.711
0
-0.291
0
-265.06
-52.3 %
0
—
0
-265.03
-52.3 %
0
-0.544
487.62
—
—
100
—
0
—
—
0
90.051
0
27.247
0
121.34
132.3 %
0
-121.34
-132.3 %
0
-17.542
0
-0.182
0
-174.07
-197.4 %
0
—
0
-174.02
-198.2 %
0
-0.435
400
—
—
100
—
0
—
—
0
38.591
0
15.51
0
52.224
46.4 %
0
-52.224
-46.4 %
0
9.82
0
-0.175
0
-58.521
-15.8 %
0
—
0
-58.356
-15.7 %
0
-0.146
400
—
—
100
—
0
—
—
0
23.953
0
12.25
0
35.683
—
0
-35.683
—
0
0.504
0
-7.251
0
-50.533
—
0
—
0
-50.445
—
0
-0.126
400